Lupus nephritis future or investigational therapies: Difference between revisions
No edit summary |
|||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Lupus nephritis}} | {{Lupus nephritis}} | ||
{{CMG}} | {{CMG}} '''Associate Editor(s)-in-Chief:''' [[User:Okamal|Omer Kamal, M.D.]][mailto:okamal@bidmc.harvard.edu <nowiki>[2]</nowiki>] | ||
==Overview== | ==Overview== | ||
==Future or Investigational Therapies== | ==Future or Investigational Therapies== | ||
Other immunosuppressants and [[bone marrow transplant|autologous stem cell transplants]] are under investigation as a possible cure. Recently, treatments that are more specific in modifying the particular subset of the immune cells (e.g. B- or T- cells) or [[cytokine]] proteins they secrete have been gaining attention. Research into new treatments has recently been accelerated by genetic discoveries, especially mapping of the [[human genome]]. According to a June 2006 market analysis report by Datamonitor, treatment for SLE could be on the verge of a breakthrough as there are numerous late-Phase trials currently being carried out.<ref>[http://www.leaddiscovery.co.uk/reports/pharmaceutical_reports/Systemic_Lupus_Erythematosus-On_the_Verge_of_a_Breakthough.html Lead Discovery article on treatment of Lupus]</ref> | |||
==References== | ==References== |
Latest revision as of 17:47, 20 July 2018
Lupus nephritis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lupus nephritis future or investigational therapies On the Web |
American Roentgen Ray Society Images of Lupus nephritis future or investigational therapies |
Lupus nephritis future or investigational therapies in the news |
Blogs on Lupus nephritis future or investigational therapies |
Risk calculators and risk factors for Lupus nephritis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]
Overview
Future or Investigational Therapies
Other immunosuppressants and autologous stem cell transplants are under investigation as a possible cure. Recently, treatments that are more specific in modifying the particular subset of the immune cells (e.g. B- or T- cells) or cytokine proteins they secrete have been gaining attention. Research into new treatments has recently been accelerated by genetic discoveries, especially mapping of the human genome. According to a June 2006 market analysis report by Datamonitor, treatment for SLE could be on the verge of a breakthrough as there are numerous late-Phase trials currently being carried out.[1]